| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $168.5M | +15.5% | +23.2% |
| Cost of Revenue | $16.4M | +4.0% | +20.1% |
| Gross Profit | $152.1M | +16.9% | +23.5% |
| R&D Expense | $30.2M | +12.7% | +30.0% |
| SG&A Expense | $19.0M | +53.1% | +88.5% |
| Operating Income | $63.7M | +16.8% | +19.8% |
| Pre-tax Income | $72.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $169.2M | +23.3% | -8.1% |
| Accounts Receivable | $129.3M | -8.7% | +3.6% |
| Current Assets | $1.09B | +5.6% | +14.0% |
| Total Assets | $1.26B | +4.4% | +12.4% |
| Current Liabilities | $140.3M | -12.3% | +6.0% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $156.0M | +151.3% | — |
| Investing Cash Flow | -$29.0M | -1183.7% | — |
| Financing Cash Flow | -$167.4M | -22.1% | — |
| +13.7% |
| +17.3% |
| Income Tax | $10.9M | +0.5% | -39.6% |
| Net Income | $62.1M | +16.4% | +40.6% |
| EPS (Basic) | $0.33 | +17.9% | +37.5% |
| EPS (Diluted) | $0.31 | +14.8% | +40.9% |
| $161.6M |
| -9.7% |
| +2.7% |
| Stockholders' Equity | $1.10B | +6.8% | +14.0% |